newsfilter
← Latest News
GlobeNewswire·

PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics demonstrated responses across multiple tumor types with